Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study. https://www.sciencedaily.com/releases/2021/07/210721141945.htm